Ad is loading...
MENU

VTGN VistaGen Therapeutics Forecast, Technical & Fundamental Analysis

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VTGN is expected to report earnings to fall 94.68% to -5 cents per share on June 27

VistaGen Therapeutics VTGN Stock Earnings Reports
Q1'23
Est.
$-0.05
Q2'23
Beat
by $1.31
Q4'22
Beat
by $0.02
Q3'22
Missed
by $0.01
Q2'22
Missed
by $0.02
The last earnings report on August 10 showed earnings per share of -93 cents, beating the estimate of -225 cents. With 356.68K shares outstanding, the current market capitalization sits at 73.23M.
A.I. Advisor
published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RTX118.530.24
+0.20%
RTX Corp
GRND14.15-0.17
-1.19%
Grindr
NBN99.48-1.46
-1.45%
Northeast Bank
ACHC37.82-1.54
-3.91%
Acadia Healthcare Company
MDXH1.64-0.11
-6.29%
MDxHealth SA

VTGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.66%
NTLA - VTGN
46%
Loosely correlated
-7.61%
ALT - VTGN
43%
Loosely correlated
-9.99%
CRSP - VTGN
43%
Loosely correlated
+0.85%
KYMR - VTGN
43%
Loosely correlated
-8.67%
IOVA - VTGN
43%
Loosely correlated
-4.77%
More